Home
AB Science

AB Science Market Share Analysis for May 2026

Discover the media coverage of AB Science activities, news, press publications, videos, posts and articles.

Health > Biotechnology and Pharmaceuticals

Domainab-science.com

Year Founded2001

Employees51 - 200

Annual Revenue> $1B

AB Science

AB Science (including company regionals)

ab-science.com

See more website traffic and engagement information

AB Science Revenue up to May 2026 is > 1B

revenue generated by AB Science top domains

AB Science top domains revenue over 3 years

Revenue for AB Science top domains

ab-science.com> 1B

See more with Sales Intelligence

Total visits to AB Science's top domains

Understand AB Science market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ab-science.com5.6K

See more with Sales Intelligence

Avg. visit duration in AB Science's top domains

Analyze AB Science engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ab-science.com00:00:31

See more with Sales Intelligence

Avg. pageviews on AB Science's top domains

See how AB Science keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ab-science.com2.01

See more with Sales Intelligence

AB Science top competitors by domain

Top similar sites in May 2026, ranked by their affinity

bayer.itCompany NameBayer CropscienceEmployees51 - 200HQItalyAnnual revenue--Total visits35.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by AB Science

These are the website technologies, by industry, used by AB Science top domains

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

Content Management System (3)

WordPress

Mobile (3)

Meta Viewport

More Technologies

6

See all

News & Signals from AB Science

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAB Science SA will attend event 2026 ENCALS annual meeting on Jun 24th '26.AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS.

NewsAB Science SA launches Phase 3 trial of masitinib for ALS.AB Science to launch new Phase 3 trial of masitinib for ALS.

NewsAB Science SA recognized as European Committee for Treatment and Research in Multiple Sclerosis on Sep 23rd '24.AB Science SA (Euronext - FR0010557264 - AB) today provides an update on the development of masitinib in progressive forms of multiple sclerosis (MS), following the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 conference.